Featured News


English

The Center for Cancer Research (CCR) of the National Cancer Institute (NCI)/NIH, headed by Dr. Dimiter S. Dimitrov, and SNBL USA recently conducted a pharmacokinetic study with a bispecific monoclonal antibody targeting a cancer-related protein, IGF2. The results serve as a basis for further investigations which could lead to novel approaches for therapy of tumors that have this specific protein.